Trifluoromethylphenylpiperazine

Trifluoromethylphenylpiperazine
Clinical data
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	AU: S9 (Prohibited substance); BR: Class F2 (Prohibited psychotropics); CA: Schedule III; DE: Anlage II (Authorized trade only, not prescriptible); NZ: Class C; US: Scheduled in Florida; Unscheduled Federally; II-P (Poland);
Pharmacokinetic data
Metabolism	Liver; CYP2D6, CYP1A2, CYP3A4
Identifiers
	IUPAC name 1-[3-(trifluoromethyl)phenyl]piperazine;
CAS Number	15532-75-9 ;
PubChem CID	4296;
ChemSpider	4145 ;
UNII	25R3ONU51C;
KEGG	C22745 ;
ChEBI	CHEBI:83536 ;
CompTox Dashboard (EPA)	DTXSID10165876 ;
ECHA InfoCard	100.035.962
Chemical and physical data
Formula	C11H13F3N2
Molar mass	230.234 g·mol−1
	InChI InChI=1S/C11H13F3N2/c12-11(13,14)9-3-1-2-4-10(9)16-7-5-15-6-8-16/h1-4,15H,5-8H2 ; Key:VZUBMIDXJRGARE-UHFFFAOYSA-N ;
	(what is this?) (verify)

3-Trifluoromethylphenylpiperazine (TFMPP) is a recreational drug of the phenylpiperazine chemical class and is a substituted piperazine. Usually in combination with benzylpiperazine (BZP) and other analogues, it is sold as an alternative to the illicit drug MDMA ("Ecstasy").

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.